<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03690297</url>
  </required_header>
  <id_info>
    <org_study_id>29052018_LCI</org_study_id>
    <nct_id>NCT03690297</nct_id>
  </id_info>
  <brief_title>Linked Color Imaging (LCI) for Colorectal Adenoma Detection</brief_title>
  <official_title>Linked Color Imaging (LCI) Versus Standard White-light Colonoscopy for Colorectal Adenoma Detection: a Multicenter, Randomized, Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Valduce Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Valduce Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Linked color imaging (LCI) is newly developed image-enhancing endoscopy technology that&#xD;
      differentiates the red color spectrum more effectively than white light imaging thanks to its&#xD;
      optimal pre-process composition of light spectrum and advanced signal processing. This&#xD;
      technology, combined in the latest generation Fujifilm's endoscopes (Fujifilm Co, Tokyo,&#xD;
      Japan) with new high-performance LED illumination system, enhances the visibility of colonic&#xD;
      mucosal vessels and might increase the detection rate of colorectal polyps. Data available&#xD;
      regarding colorectal polyp or adenoma detection with LCI are encouraging but are scanty and&#xD;
      limited to back-to back studies.&#xD;
&#xD;
      This two parallel arms, randomized, multicenter trial is aimed at evaluating whether LCI is&#xD;
      superior to WL endoscopy in terms of adenoma detection&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      50-75 years-old subjects participating in the regional screening program undergoing their&#xD;
      first colonoscopy following a positive immunochemical fecal occult blood test (FIT) and&#xD;
      meeting all eligibility criteria are randomised 1:1 to LCI (LCI group) or WLI (WL) during&#xD;
      insertion and withdrawal phase of colonoscopy. A randomisation list for each participating&#xD;
      center was produced by the coordinating center via computer-generated treatment code list.&#xD;
      Randomisation is stratified by gender, age (50-60, 61-729 years) and screening history (first&#xD;
      vs subsequent test) through an online centralised study database.All procedures are performed&#xD;
      with a high-definition ELUXEO 700 series videocolonscopes with or without magnification&#xD;
      (EC-760R, EC-760ZP, FUJIFILM Co., Tokyo).&#xD;
&#xD;
      The primary outcome measure is the ADR, defined as the proportion of participants with at&#xD;
      least one adenoma (per-patient analysis).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2018</start_date>
  <completion_date type="Actual">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 21, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma Detection Rate</measure>
    <time_frame>1 year</time_frame>
    <description>proportion of participants with at least one adenoma (per-patient analysis)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>advanced adenoma detection rate</measure>
    <time_frame>1 year</time_frame>
    <description>proportion of participants with at least one advanced adenoma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean number per subject of polyps, adenomas, advanced adenomas and sessile serrated lesions</measure>
    <time_frame>1 year</time_frame>
    <description>total number of detected lesions in each group divided by the total number of participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Withdrawal time</measure>
    <time_frame>1 year</time_frame>
    <description>time for mucosal inspection only</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">600</enrollment>
  <condition>Colon Adenoma</condition>
  <condition>Colonic Polyp</condition>
  <arm_group>
    <arm_group_label>LCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Linked Color Imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>White Light</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Linked Color Imaging</intervention_name>
    <description>Use of narrow band imaging with LCI for colon inspection during both insertion and withdrawal phase of colonoscopy</description>
    <arm_group_label>LCI</arm_group_label>
    <arm_group_label>WL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  50-75 years-old subjects participating in the regional screening program undergoing&#xD;
             their first colonoscopy following a positive immunochemical fecal occult blood test&#xD;
             (FIT)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subjects not eligible for invitation in the screening program (colonoscopy already&#xD;
             performed in the previous 5 years, personal history of CRC, colonic adenomas or IBD,&#xD;
             severe comorbidity, including end-stage cardiovascular, pulmonary, liver or renal&#xD;
             disease)&#xD;
&#xD;
          -  patients with inadequate bowel preparation (defined as Boston Bowel Preparation Scale&#xD;
             &gt; 2 in any colonic segment)&#xD;
&#xD;
          -  patients with previous colonic resection&#xD;
&#xD;
          -  patients on antithrombotic therapy, precluding polyp resection&#xD;
&#xD;
          -  patients who were not able or refused to give informed written consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>72 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franco Radaelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Valduce Hospital, Como</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gastroenterology Unit, Valduce Hospital</name>
      <address>
        <city>Como</city>
        <zip>22100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 18, 2018</study_first_submitted>
  <study_first_submitted_qc>September 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2018</study_first_posted>
  <last_update_submitted>October 1, 2019</last_update_submitted>
  <last_update_submitted_qc>October 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Valduce Hospital</investigator_affiliation>
    <investigator_full_name>Franco Radaelli</investigator_full_name>
    <investigator_title>Principal Investigator, Head Endoscopy Unit, Valduce Hospital</investigator_title>
  </responsible_party>
  <keyword>adenoma detection rate</keyword>
  <keyword>Linked Color Imaging</keyword>
  <keyword>colonoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

